These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12413619)

  • 1. Does contraceptive method change the Pap smear finding?
    Kazerooni T; Mosalaee A
    Contraception; 2002 Oct; 66(4):243-6. PubMed ID: 12413619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical importance of detection of bacterial vaginosis, trichomonas vaginalis, candida albicans and actinomyces in Papanicolaou smears.
    Güdücü N; Gönenç G; Işçi H; Yiğiter AB; Başsüllü N; Dünder I
    Clin Exp Obstet Gynecol; 2012; 39(3):333-6. PubMed ID: 23157037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between contraceptive method and vaginal flora.
    Peddie BA; Bishop V; Bailey RR; McGill H
    Aust N Z J Obstet Gynaecol; 1984 Aug; 24(3):217-8. PubMed ID: 6596089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonbarrier contraceptives and vaginitis and vaginosis.
    Roy S
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1240-4. PubMed ID: 1951581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actinomycosis infection associated with intrauterine contraceptive devices.
    Keebler C; Chatwani A; Schwartz R
    Am J Obstet Gynecol; 1983 Mar; 145(5):596-9. PubMed ID: 6829637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods of contraception and rates of genital infections.
    Ceruti M; Canestrelli M; Condemi V; Piantelli G; De Paolis P; Amone F; Tovagliari D
    Clin Exp Obstet Gynecol; 1994; 21(2):119-23. PubMed ID: 8070115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with actinomyces-like organisms on Papanicolaou smear in users of intrauterine contraceptive devices.
    Petitti DB; Yamamoto D; Morgenstern N
    Am J Obstet Gynecol; 1983 Feb; 145(3):338-41. PubMed ID: 6824023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
    Vessey MP; Lawless M; McPherson K; Yeates D
    Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of intrauterine contraceptive devices on cytological findings from routine Pap smear testing.
    Kaplan B; Orvieto R; Hirsch M; Rabinerson D; Braslavski D; Bar-Hava I; Ben-Rafael Z
    Eur J Contracept Reprod Health Care; 1998 Jun; 3(2):75-7. PubMed ID: 9710710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular composition of cervical smears in relation to the day of the menstrual cycle and the method of contraception.
    Vooijs GP; van der Graaf Y; Elias AG
    Acta Cytol; 1987; 31(4):417-26. PubMed ID: 3604536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contraception and tubal sterility of infective origin].
    Gayer ML; Henry-Suchet J
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(2):155-64. PubMed ID: 2324437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and prevalence of IUD-associated Actinomyces colonization and related morbidity. A prospective study of 69,925 cervical smears.
    Valicenti JF; Pappas AA; Graber CD; Williamson HO; Willis NF
    JAMA; 1982 Feb; 247(8):1149-52. PubMed ID: 7057605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of contraceptive pills and intrauterine devices on urinary bladder.
    Zahran MM; Osman MI; Kamel M; Fayad M; Mooro H; Youssef AF
    Urology; 1976 Dec; 8(6):567-74. PubMed ID: 793141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of actinomyces-like organisms in Papanicolaou-stained smears of copper- and levonorgestrel-releasing intrauterine devices.
    Merki-Feld GS; Lebeda E; Hogg B; Keller PJ
    Contraception; 2000 Jun; 61(6):365-8. PubMed ID: 10958879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative study of the incidence of Gardnerella vaginalis in users of IUD and oral contraceptives].
    Aleixo Neto A; Peixoto ML; Cabral AC
    J Bras Ginecol; 1987 Jul; 97(7):315-6. PubMed ID: 12282423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraceptive choice and prevalence of cervical dysplasia and carcinoma in situ.
    Ory H; Naib Z; Conger SB; Hatcher RA; Tyler CW
    Am J Obstet Gynecol; 1976 Mar; 124(6):573-7. PubMed ID: 1258912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of cervical-vaginal infections in the pap-smear samples in Iran.
    Maria C; Zahra R; Sara P
    Glob J Health Sci; 2013 Dec; 6(1):201-6. PubMed ID: 24373280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genital actinomycosis and intrauterine contraceptive devices. Cytopathologic diagnosis and clinical significance.
    Bhagavan BS; Gupta PK
    Hum Pathol; 1978 Sep; 9(5):567-78. PubMed ID: 711232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible contraception for the woman over 35 years of age.
    Archer DF
    Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women.
    Oddens BJ
    Contraception; 1999 May; 59(5):277-86. PubMed ID: 10494480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.